financetom
Business
financetom
/
Business
/
Eton Pharmaceuticals Insider Sold Shares Worth $673,714, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eton Pharmaceuticals Insider Sold Shares Worth $673,714, According to a Recent SEC Filing
Aug 20, 2025 2:37 PM

05:18 PM EDT, 08/20/2025 (MT Newswires) -- James R. Gruber, Chief Financial Officer, on August 19, 2025, sold 41,713 shares in Eton Pharmaceuticals ( ETON ) for $673,714. Following the Form 4 filing with the SEC, Gruber has control over a total of 204,753 common shares of the company, with 204,753 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1710340/000143774925027464/xslF345X05/rdgdoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
JFrog Q1 Non-GAAP EPS, Revenue Rise; Q2 Guidance Set; 2024 Outlook Raised
JFrog Q1 Non-GAAP EPS, Revenue Rise; Q2 Guidance Set; 2024 Outlook Raised
May 9, 2024
05:01 PM EDT, 05/09/2024 (MT Newswires) -- JFrog ( FROG ) reported Q1 non-GAAP earnings late Thursday of $0.16 per diluted share, up from $0.06 a year earlier. Analysts polled by Capital IQ expected $0.14. Subscription revenue for the quarter ended March 31 was $100.3 million, up from $79.8 million a year earlier. Analysts surveyed by Capital IQ expected $98.6...
Crinetics Pharmaceuticals Q1 Net Loss Widens
Crinetics Pharmaceuticals Q1 Net Loss Widens
May 9, 2024
05:03 PM EDT, 05/09/2024 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) reported Q1 net loss Thursday of $0.93 per diluted share, widening from the loss of $0.85 a year earlier. Analysts polled by Capital IQ expected a loss of $0.80. Revenue in the three months ended March 31 fell to $640,000 from $2.68 million a year earlier. The company...
Salesforce Insider Sold Shares Worth $4,179,383, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $4,179,383, According to a Recent SEC Filing
May 9, 2024
05:03 PM EDT, 05/09/2024 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on May 08, 2024, sold 15,000 shares in Salesforce ( CRM ) for $4,179,383. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,632,327 shares of the company, with 12,632,327 shares held directly and 10,000,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224014808/xslF345X03/form4.xml Price:...
Array Technologies Stock Heats Up On Q1 Earnings As Momentum From Q4 Continues Into New Year
Array Technologies Stock Heats Up On Q1 Earnings As Momentum From Q4 Continues Into New Year
May 9, 2024
Array Technologies Inc ( ARRY ) shares are trading higher in Thursday’s after-hours session on the heels of the company’s first-quarter financial results. Here’s a rundown of the report. Q1 Revenue: $153.4 million, versus estimates of $140.106 million Q1 EPS: Loss of 7 cents/ Adjusted EPS 6 cents “We started 2024 off strong as the momentum observed in the fourth quarter of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved